AKTX 10-Q: SEC filing
Akari Therapeutics Plc
Filed with the SEC on · accession 0001493152-26-051372
AKTX filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. Akari Therapeutics Plc filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and ongoing operations. The stock moved -12.6% by the first close after the filing.
Summary of the filing
Akari Therapeutics Plc filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and ongoing operations. The filing includes standard financial statements and disclosures for the quarter.
Key details
How AKTX stock reacted
Close before
$7.45
Nov 11, 2026
First close after
-12.62%
$6.51
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for AKTX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for AKTX?
Click hereFrequently asked questions
What did AKTX file with the SEC on Nov 12, 2026?
AKTX filed a 10-Q (SEC filing). Akari Therapeutics Plc filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and ongoing operations. The filing includes standard financial statements and disclosures for the quarter.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did AKTX stock react to this filing?
AKTX closed at $7.45 before the filing and $6.51 on Nov 12, 2026 (-12.62%).
Other AKTX SEC filings
- SCHEDULE 13G/A · SEC filingNov 12, 2026
- 8-K · SEC filingNov 12, 2026
- 8-K · SEC filingOct 30, 2026
- DEF 14A · SEC filingOct 1, 2026
- 8-K · SEC filingOct 1, 2026
- 10-Q · SEC filingAug 13, 2026
- 8-K · SEC filingAug 13, 2026
- SCHEDULE 13G · SEC filingAug 12, 2026
- S-3 · Shelf registrationJul 10, 2026
- S-3/A · Shelf registrationJul 8, 2026
Get alerts when AKTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days